Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/09/057996
CTRI/2023/09/057996
Not yet recruiting
Phase 2

Clinical Study to evaluate the Effectiveness of Raajavrukshadi Kashaya Yoni Prakshalana and Panchakashaya Taila Yoni Pichu in the Management of Kaphaja Yonivyapath. - NI

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Thanniruhalla BMRoad Hassan0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Thanniruhalla BMRoad Hassan
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Thanniruhalla BMRoad Hassan

Eligibility Criteria

Inclusion Criteria

  • •Presence of Yonisrava and Yoni Kandu with or without Yoni alpavedana.
  • •Married women of age between 20\-50years.
  • •Willing to sign the informed written consent form.

Exclusion Criteria

  • •Pregnant women
  • •Lactating women.
  • •Cervical pathology like Carcinoma of cervix, polyps, etc
  • •Subjects positive for HIV, VDRL, HBsAg
  • •Known case of Diabetes mellitus, pelvic inflammatory disease
  • •Post menopausal women.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
To study the effect of Ayurvedic formulations on Vataja Badhirya/SNHL.
CTRI/2022/06/043211ational Institute Of Ayurveda30
Not yet recruiting
Not Applicable
Ayurvedic management of BPH with vastyamayanthak ghrita as uttara vasti and rasa sindura orallyHealth Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
CTRI/2024/07/071342Dr BRKR GOVT AYURVEDIC MEDICAL COLLEGE AND HOSPITA
Active, not recruiting
Not Applicable
A phase II study to investigate the efficacy of RAD001 (Afinitor®, everolimus) in patients with irresectable recurrent or metastatic differentiated, undifferentiated (anaplastic) and medullary thyroid carcinoma - THYRRAD, CRAD001CNL08TPatients with irresectable recurrent or metastatic differentiated, undifferentiated (anaplastic) and medullary thyroid carcinoma will be treated in a phase II study to investigate the efficacy of RAD001 (Afinitor®, everolimus).
EUCTR2009-016669-27-NLeiden University Medical Center
Completed
Phase 2
A phase II study to investigate the efficacy of RAD001 (Afinitor ®, everolimus) in patients with irresectable recurrent or metastatic differentiated, undifferentiated (anaplastic) and medullary thyroid carcinoma
NL-OMON35047eids Universitair Medisch Centrum42
Not yet recruiting
Phase 3
An Ayurvedic Management Of Dry Eye SyndromeHealth Condition 1: H041- Other disorders of lacrimal gland
CTRI/2023/07/055410Dr Shruti D Gangannavar